If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...

Several known risk factors of Dermatomyositis (DM ... She is recognized for her contributions to advancing treatment options and understanding of these challenging conditions.

The following is a summary of “A systematic review and meta-analysis of the response to placebo in clinical trials of ...

Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ...

An acute necrotising myopathy is a distinct form of uncommon muscle disease characterised by the rapid advancement of ...

Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T cells, today announced that the ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire David Einhorn. David Einhorn is a highly ...